Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Peglispro vs Insulin Glargine in Asian T2DM Patients
NCT01894568Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2013
- Primary completion
- Apr 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jul 2013; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01894568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894568.